Prodigiosins: A novel family of immunosuppressants with anti-cancer activity

Indian Journal of Biochemistry and Biophysics

Volumn 44, Issue 5, 2007, Pages 295-302

  Pandey, Ruchi ^a   Chander, Ramesh ^a   Sainis, Krishna B ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Anti cancer activity; Immunosuppressants; Prodigiosins

Indexed keywords

NEGIBACTERIA;

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PRODIGIOSIN;

ANIMAL; BIOLOGICAL MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; NEOPLASM; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; MODELS, IMMUNOLOGICAL; NEOPLASMS; PRODIGIOSIN;

EID: 84924240259     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Bennett J W & Bentley R (2000) Adv Appl Microbiol 47, 1-32
2. Gerber N N (1975) CRC Crit Rev Microbiol 3, 469-485
3. Williams R P & Quadri S M (1980) In: The Genus Serratia (Von-Graevenitz A & Rubin S J, eds), pp. 31-75, Boca Raton: CRC Press Inc
4. Variyar P S, Chander R, Venkatachalam S R & Bongirwar D R (2002) Indian J Chem 41, 232-233
5. Deorukhkar A A, Chander R, Ghosh S B & Sainis K B (2007) Res Microbiol 158, 399-404
6. Manderville R A (2001) Curr Med Chem Anticancer Agents 1, 195-218
7. Nakamura A, Nagai K, Ando K & Tamura G (1986) J Antibiot (Tokyo) 39, 1155-1159
8. Tsuji R F, Yamamoto M, Nakamura A, Kataoka T, Magae J, Nagai K & Yamasaki M (1990) J Antibiot (Tokyo) 43, 1293-1301
9. Kawauchi K, Shibutani K, Yagisawa H, Kamata H, Nakatsuji S, Anzai H, Yokoyama Y, Ikegami Y, Moriyama Y & Hirata H (1997) Biochem Biophys Res Commun 237, 543-547
10. Han S B, Kim H M, Kim Y H, Lee C W, Jang E S, Son K H, Kim S U, Kim Y K (1998). Int J Immunopharmacol 20, 1-13
11. Azuma T, Watanabe N, Yagisawa H, Hirata H, Iwamura M & Kobayashi Y (2000) Immunopharmacol 46, 29-37
12. Han S B, Park S H, Jeon Y J, Kim Y K, Kim H M & Yang K H (2001) J Pharmacol Exp Ther 299, 415-425
13. Pandey R, Chander R & Sainis K B (2003) Int Immunopharmacol 3, 159-167
14. Pandey R (2006) Immunosuppressive activity of a prodigiosin like pigment from Micrococcus sp, Ph. D. thesis. University of Mumbai, Mumbai
15. Han S B, Lee C W, Yoon Y D, Kang J S, Lee K H, Yoon W K, Kim Y K, Lee K, Park S K & Kim H M (2005) Biochem Pharmacol 70, 1518-1526
16. Songia S, Mortellaro A, Taverna S, Fornasiero C, Scheiber E A, Erba E, Colotta F, Mantovani A, Isetta A M & Golay J (1997) J Immunol 158, 3987-3995
17. Mortellaro A, Songia S, Gnocchi P, Ferrari M, Fornasiero C, ' D'Alessio R, Isetta A, Colotta F & Golay J (1999) J Immunol 162, 7102-7109
18. Magae J, Yamashita M & Nagai K (1993) Ann N Y Acad Sci 685, 339-340
19. Lee M H, Yamashita M, Tsuji R F, Yamasaki M, Kataoka T, Magae J & Nagai K (1998) J Antibiot (Tokyo) 51, 92-94
20. Lee M, Kataoka T, Magae J & Nagai K (1995) Biosci Biotechnol Biochem 59, 1417-1421
21. Van den Steen P, Rudd P M, Dwek R A, Van Damme J & Opdenakker G (1998) Adv Exp Med Biol 435, 133-143
22. Kataoka T, Muroi M, Ohkuma S, Waritani T, Magae J, Takatsuki A, Kondo S, Yamasaki M & Nagai K (1995) FEBS Lett 359, 53-59
23. Nakashima T, Tamura T, Kurachi M, Yamaguchi K & Oda T (2005) Biol Pharm Bull 28, 2289-2295
24. Nakashima T, Kurachi M, Kato Y, Yamaguchi K & Oda T (2005) Microbiol Immunol 49, 407-415
25. Smith K A (1980) Immunol Rev 51, 337-357
26. Stepkowski S M, Nagy Z S, Wang M E, Behbod F, Erwin-Cohen R, Kahan B D & Kirken R A (2001) Transplant Proc 33, 3272-3273
27. Wang M, Kirken R, Behbod F, Erwin-Cohen R, Stepkowski S M, Kahan B D (2001) Transplant Proc 33, 201
28. Stepkowski S M, Erwin-Cohen R A, Behbod F, Wang M E, Qu X, Tejpal N, Nagy Z S, Kahan B D & Kirken R A (2002) Blood 99, 680-689
29. He Y W & Malek T R (1998) Crit Rev Immunol 18, 503-524
30. Leonard W J & O'Shea J J (1998) Annu Rev Immunol 16, 293-322
31. Habib T, Senadheera S, Weinberg K & Kaushansky K (2002) Biochemistry 41, 8725-8731
32. Parrish-Novak J, Foster D C, Holly R D & Clegg C H (2002) J Leukoc Biol 72, 856-863
33. Cetkovic-Cvrlje M & Uckun F M (2004) Arch Immunol Ther Exp 52, 69-82
34. Fodder H & Kahan B D (2004) Expert Opin Ther Targets 8, 613-629
35. Changelian P S, Flanagan M E, Ball D J, Kent C R, Magnuson K S, Martin W H, Rizzuti B J, Sawyer P S, Perry B D, Brissette W H, McCurdy S P, Kudlacz E M, Conklyn M J, Elliott E A, Koslov E R, Fisher M B, Strelevitz T J, Yoon K, Whipple D A, Sun J, Munchhof M J, Doty J L, Casavant J M, Blumenkopf T A, Hines M, Brown M F, Lillie B M, Subramanyam C, Shang-Poa C, Milici A J, Beckius G E, Moyer J D, Su C, Woodworth T G, Gaweco A S, Beals C R, Littman B H, Fisher D A, Smith J F, Zagouras P, Magna H A, Saltarelli M J, Johnson K S, Nelms L F, Des Etages S G, Hayes L S, Kawabata T T, Finco-Kent D, Baker D L, Larson M, Si M S, Paniagua R, Higgins J, Holm B, Reitz B, Zhou Y J, Morris R E, O'Shea J J & Borie D C (2003) Science 302, 875-878
36. Kamata K, Okamoto S, Oka S, Kamata H, Yagisawa H & Hirata H (2000) FEBS Lett 507, 74-80
37. Carter A B, Knudtson K L, Monick M M & Hunninghake G W (1999) J Biol Chem 274, 30858-30863
38. Montaner B & Perez-Tomas R (2003) Curr Cancer Drug Targets 3, 57-65
39. Perez-Tomas R, Montaner B, Llagostera E & Soto-Cerrato V (2003) Biochem Pharmacol 66, 1447-1452
40. Ramoneda B M & Perez-Tomas R (2002) Biochem Pharmacol 63, 463-469
41. Nakamura A, Magae J, Tsuji R F, Yamasaki M & Nagai K (1989) Transplantation 47, 1013-1016
42. Magae J, Miller M W, Nagai K, Shearer G M (1996) J Antibiot (Tokyo) 49, 86-90
43. Lee M H, Kataoka T, Honjo N, Magae J & Nagai K (2000) Immunology 99, 243-248
44. Nakai K, Hamada Y, Kato Y, Yamamoto D, Hirata H & Hioki K (2000) Transplantation Proc 32, 1324-1325
45. Metcalfe S, Ashley N, Chen Z & Calne R Y (1993) Int Arch Allergy Immunol 101, 132-135
46. Stepkowski S M & Kahan B D (1991) Transplant Proc 23, 3262-3264
47. Kahan B D, Stepkowski S M, Napoli K L, Katz S M, Knight R J & Van Buren C (2000) Clin Transpl 14, 145-158
48. MacDonald A S (2001) RAPAMUNE Global study group (Writing Committee - Falk Michael, MacDonald A, Nanni Giuseppe N & Sindhi R) Transplantation 71, 271-280
49. Yamamoto C, Takemoto H, Kuno K, Yamamoto D, Tsubura A, Kamata K, Hirata H, Yamamoto A, Kano H, Seki T & Inoue K (1999) Hepatology 30, 894-902
50. Montaner B, Navarro S, Pique M, Vilaseca M, Martinell M, Giralt E, Gil J & Perez-Tomas R (2000) Br J Pharmacol 131, 585-593
51. Yamamoto D, Kiyozuka Y, Uemura Y, Yamamoto C, Takemoto H, Hirata H, Tanaka K, Hioki, K & Tsubura A (2000) J Cancer Res Clin Oncol 126, 191-197
52. Yamamoto D, Uemura Y, Tanaka K, Nakai K, Yamamoto C. Takemoto H, Kamata K, Hirata H & Hioki K (2000) Int J Cancer 88, 121-128
53. Yamamoto C, Takemoto H, Kuno K, Yamamoto D, Nakai K, Baden T, Kamata K, Hirata H, Watanabe T & Inoue K (2001) Oncol Rep 8, 821-824
54. Montaner B & Perez-Tomas R (2001) Life Sci 68, 2025-2036
55. Diaz-Ruiz C, Montaner B & Perez-Tomas R (2001) Histol Histopathol 16, 415-421
56. Soto-Cerrato V, Llagostera E, Montaner B, Scheffer G L & Perez-Tomas R (2004) Biochem Pharmacol 68, 1345-1352
57. Llagostera E, Soto-Cerrato V, Joshi R, Montaner B. Gimenez-Bonafe P & Perez-Tomas R (2005) Anticancer Drugs 16, 393-399
58. Liu R, Cui C B, Duan L, Gu Q Q & Zhu W M (2005) Arch Pharm Res 28, 1341-1344
59. Deorukhkar A A, Chander R, Pandey R & Sainis K B (2007) Cancer Chemother Pharmacol DOI 10.1007/s00280-007-0475-y
60. Baldino C M, Parr J, Wilson C J, Ng S C, Yohannes D & Wasserman H H (2006) Bioorg Med Chem Lett 16, 701-704
61. Campas C, Dalmau M, Montaner B, Barragan M, Bellosillo B, Colomer D, Pons G, Perez-Tomas R & Gil J (2003) Leukemia 17, 746-750
62. Zhang J, Shen Y, Liu J & Wei D (2005) Biochem Pharmacol 69, 407-414